SecBot SecBot
← Back to Analyst Consensus
ESPR Hold

Esperion Therapeutics, Inc.

Current Price —
Implied Upside —
Analysts 11

30-Day Momentum

▲ 0 upgrades  /  ▼ 0 downgrades  /  0 reiterations  from 0 firms

Next Earnings

Nov 4, 2026 (9 days)

Rating Timeline

Date ▼FirmActionFrom → To RatingPrice TargetFirm Rating
May 4, 2026NeedhamdowngradeBuy → Hold—50%
May 1, 2026HC Wainwright & Co.downgradeBuy → Neutral—44%
Mar 13, 2026CitizensmaintainMarket Outperform → Market Outperform—47%
Mar 3, 2026NeedhammaintainBuy → Buy—50%
Nov 25, 2025Piper Sandlerinitiate— → Overweight$954%
Sep 19, 2025HC Wainwright & Co.reiterateBuy → Buy$1644%
Jun 17, 2025HC Wainwright & Co.reiterateBuy → Buy$1644%
May 7, 2025NeedhammaintainBuy → Buy$450%
Apr 25, 2025HC Wainwright & Co.reiterateBuy → Buy$1644%
Apr 25, 2025NeedhamreiterateBuy → Buy$550%
Apr 17, 2025Goldman SachsmaintainNeutral → Neutral$354%
Apr 8, 2025NeedhamreiterateBuy → Buy$550%
Mar 20, 2025HC Wainwright & Co.reiterateBuy → Buy$1644%
Mar 5, 2025Citizens Capital MarketsreiterateMarket Outperform → Market Outperform$449%
Mar 4, 2025HC Wainwright & Co.reiterateBuy → Buy$1644%
Feb 11, 2025JMP SecuritiesreiterateMarket Outperform → Market Outperform$453%
Feb 11, 2025HC Wainwright & Co.reiterateBuy → Buy$1644%
Jan 23, 2025JMP SecuritiesreiterateMarket Outperform → Market Outperform$753%
Jan 23, 2025HC Wainwright & Co.reiterateBuy → Buy$1644%
Jan 22, 2025HC Wainwright & Co.reiterateBuy → Buy$1644%
Jan 10, 2025HC Wainwright & Co.reiterateBuy → Buy$044%
Dec 17, 2024Cantor Fitzgeraldinitiate— → Overweight$850%
Dec 13, 2024NeedhamreiterateBuy → Buy$650%
Dec 13, 2024HC Wainwright & Co.reiterateBuy → Buy$1644%
Dec 12, 2024HC Wainwright & Co.reiterateBuy → Buy$1644%
Dec 3, 2024HC Wainwright & Co.maintainBuy → Buy$1644%
Dec 2, 2024HC Wainwright & Co.reiterateBuy → Buy$1644%
Nov 27, 2024HC Wainwright & Co.reiterateBuy → Buy$1644%
Nov 19, 2024HC Wainwright & Co.reiterateBuy → Buy$1644%
Nov 8, 2024HC Wainwright & Co.reiterateBuy → Buy$1644%
Oct 2, 2024HC Wainwright & Co.reiterateBuy → Buy$1644%
Aug 13, 2024NeedhammaintainBuy → Buy$650%
Aug 12, 2024HC Wainwright & Co.reiterateBuy → Buy$1644%
Jun 28, 2024NeedhamreiterateBuy → Buy$850%
Jun 28, 2024HC Wainwright & Co.reiterateBuy → Buy$1644%
Jun 20, 2024B of A SecuritiesdowngradeNeutral → Underperform$2.553%
May 22, 2024HC Wainwright & Co.reiterateBuy → Buy$1644%
May 21, 2024HC Wainwright & Co.reiterateBuy → Buy$1644%
May 8, 2024HC Wainwright & Co.reiterateBuy → Buy$1644%
May 7, 2024NeedhamreiterateBuy → Buy$850%
Apr 10, 2024NeedhamreiterateBuy → Buy$850%
Mar 25, 2024HC Wainwright & Co.reiterateBuy → Buy$1644%
Mar 25, 2024NeedhamreiterateBuy → Buy$850%
Feb 28, 2024HC Wainwright & Co.maintainBuy → Buy$1644%
Feb 27, 2024NeedhamreiterateBuy → Buy$850%
Nov 13, 2023HC Wainwright & Co.reiterateBuy → Buy$2244%
Nov 7, 2023NeedhammaintainBuy → Buy$850%
Oct 2, 2023NeedhamreiterateBuy → Buy$950%
Aug 28, 2023HC Wainwright & Co.reiterateBuy → Buy$2244%
Aug 2, 2023NeedhammaintainBuy → Buy$950%

Price Target Trend

Apr 22, 2026 Latest: $3.2 Sep 10, 2026

EPS Estimates

+1y $0.26
Lo: $0.09 Hi: $0.49
4 analysts
0q $-0.07
Lo: $-0.07 Hi: $-0.07
1 analysts
▲1
+1q $-0.04
Lo: $-0.04 Hi: $-0.04
1 analysts
▲1
0y $-0.21
Lo: $-0.21 Hi: $-0.21
1 analysts
▲1

Cross-Platform Signals

No cross-platform signals in the last 90 days

Fresh Analyst Detail

Price targets, earnings estimates, and firm actions for this ticker — updated within the last 24 hours.

Subscribe for Full Access